Table 2.
Summary of various in vivo macrophage phenotypes and their identification markers reported in the literature [58].
Phenotypes | Effector molecule | Identification markers |
---|---|---|
Primary monocytes | F8/80+, MHC-II+, CSF-1R+ | CD11b+, CD115+ |
Inflammatory/circulating monocytes | CX3CR1Low, CD62L−, CD43+, Cd11c- | Ly6C+, CCR2High |
FBRa macrophages | CD64Moderate, MHC-II+ | CD6High, F4/80High |
M1 macrophages | pSTAT1, pSTAT5, iNOSHigh, IL-1R1, TLR2, TLR4, IRF-5, IL-12High, IL-23High, TNF-αHigh, IL-1βHigh, IL-6Moderate, CCL(2,3,4,5,8,9,10,11), CXCL9, CXCL10, CXCL11 | CD80+, CD86+, CCR7High, SOCS3 |
M2a macrophages | CD200R?, Stabilin-1, CD301, Dectin-1, SR, IL-1R, Polyamine, CCL17, CCL22, CCL24, TGF-βModerate | IL-10High, CD163High, SOCS1/2, Arg1High, CD206High, THM2, Fizz1Moderate, Ym1/2, pSTAT6 |
M2b macrophages | MHC-II, IL-1, IL-6, CCL1, TNF-α | CD86+ |
M2c macrophages | CD163, TGF-βHigh | MERTK, pSTAT3, CD206High |
M2d macrophages | IL-10Moderate, IL-12, TNF-α, and TGF-β | VEGF-A |
FBGCb | CD11c, CD44, CD98, CD206, E-cadherin, DC-STAMP, DC-SIGN, HLA-DR, B7-H1 | CD86, MMP9 |
Anti-fibrotic macrophages | Arg-1-, CD206, FIZZ1, MERTK, CD74, CXCR2, CXCR4, MFGE8, MMP(3,8,9,12,13,14) | Arg-1+, CD280High, PPARγ |
FBR, foreign body response.
FBGC, foreign body giant cell.